|
1
|
Kessler E and Wolloch Y: Granulomatous
mastitis: a lesion clinically simulating carcinoma. Am J Clin
Pathol. 58:642–646. 1972. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hovanessian Larsen LJ, Peyvandi B, Klipfel
N, Grant E and Iyengar G: Granulomatous lobular mastitis: Imaging,
diagnosis, and treatment. AJR Am J Roentgenol. 193:574–581. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mahlab-Guri K, Asher I, Allweis T, Diment
J, Sthoeger ZM and Mavor E: Granulomatous Lobular Mastitis. Isr Med
Assoc J. 17:476–480. 2015.PubMed/NCBI
|
|
4
|
Akcan A, Akyildiz H, Deneme MA, Akgun H
and Aritas Y: Granulomatous lobular mastitis: A complex diagnostic
and therapeutic problem. World J Surg. 30:1403–1409. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Vingerhoedt NM, Janssen S, Mravunac M,
Wauters CA and Strobbe LJ: Granulomatous lobular mastitis: a benign
abnormality that mimics malignancy. Ned Tijdschr Geneeskd.
152:1052–1056. 2008.In Dutch. PubMed/NCBI
|
|
6
|
Kfoury H and Al Bhlal L: Granulomatous
lobular mastitis: A clinicopathological study of 112 cases. Ann
Saudi Med. 17:43–46. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gurleyik G, Aktekin A, Aker F, Karagulle H
and Saglamc A: Medical and surgical treatment of idiopathic
granulomatous lobular mastitis: A benign inflammatory disease
mimicking invasive carcinoma. J Breast Cancer. 15:119–123. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hoesel B and Schmid JA: The complexity of
NF-kappaB signaling in inflammation and cancer. Mol Cancer.
12:862013. View Article : Google Scholar
|
|
9
|
Kyriakis JM and Avruch J: Mammalian MAPK
signal transduction pathways activated by stress and inflammation:
A 10-year update. Physiol Rev. 92:689–737. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Guma M, Stepniak D, Shaked H, Spehlmann
ME, Shenouda S, Cheroutre H, Vicente-Suarez I, Eckmann L, Kagnoff
MF and Karin M: Constitutive intestinal NF-kappaB does not trigger
destructive inflammation unless accompanied by MAPK activation. J
Exp Med. 208:1889–1900. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen KC, Sun MF, Yang SC, Chang SS, Chen
HY, Tsai FJ and Chen CY: Investigation into potent inflammation
inhibitors from traditional Chinese medicine. Chem Biol Drug Des.
78:679–688. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huang Y, Cai T, Xia X, Cai Y and Wu XY:
Research advances in the intervention of inflammation and cancer by
active ingredients of traditional Chinese medicine. J Pharm Pharm
Sci. 19:114–126. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
National Pharmacopoeia Committee:
Pharmacopoeia of People's Republic of China [M]. Part 1. Beijing:
China Medical Science Press; pp. 85–86. 2015
|
|
14
|
Wang N, Wang Z, Peng C, You J, Shen J, Han
S and Chen J: Dietary compound isoliquiritigenin targets GRP78 to
chemosensitize breast cancer stem cells via β-catenin/ABCG2
signaling. Carcinogenesis. 35:2544–2554. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Park SY, Hwang JS, Jang M, Lee SH, Park JH
and Han IO: A novel caffeic acid-1-piperonylpiperazine
hybridization compound HBU-47 inhibits LPS-mediated inflammation in
RAW264.7 macrophage cells. Int Immunopharmacol. 19:60–65. 2014.
View Article : Google Scholar
|
|
16
|
Cho EC, Kuo ML, Cheng JH, Cheng YC, Hsieh
YC, Liu YR, Hsieh RH and Yen Y: RRM2B-mediated regulation of
mitochondrial activity and inflammation under oxidative stress.
Mediators Inflamm. 2015:2873452015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Maianskiĭ DN: The pathogenesis of chronic
inflammation. Ter Arkh. 64:3–7. 1992.In Russian.
|
|
18
|
Watanabe K, Kawamori T, Nakatsugi S and
Wakabayashi K: COX-2 and iNOS, good targets for chemoprevention of
colon cancer. Biofactors. 12:129–133. 2000. View Article : Google Scholar
|
|
19
|
Dinarello CA, Simon A and van der Meer JW:
Treating inflammation by blocking interleukin-1 in a broad spectrum
of diseases. Nat Rev Drug Discov. 11:633–652. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fonseca JE, Santos MJ, Canhão H and Choy
E: Interleukin-6 as a key player in systemic inflammation and joint
destruction. Autoimmun Rev. 8:538–542. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kzhyshkowska J, Gudima A, Moganti K,
Gratchev A and Orekhov A: Perspectives for
monocyte/macrophage-based diagnostics of chronic inflammation.
Transfus Med Hemother. 43:66–77. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Schulert GS and Grom AA: Macrophage
activation syndrome and cytokine-directed therapies. Best Pract Res
Clin Rheumatol. 28:277–292. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dinarello CA: A clinical perspective of
IL-1beta as the gatekeeper of inflammation. Eur J Immunol.
41:1203–1217. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nishimoto N and Kishimoto T: Inhibition of
IL-6 for the treatment of inflammatory diseases. Curr Opin
Pharmacol. 4:386–391. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tanaka T, Narazaki M and Kishimoto T: IL-6
in inflammation, immunity, and disease. Cold Spring Harb Perspect
Biol. 6:a0162952014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rajakariar R, Yaqoob MM and Gilroy DW:
COX-2 in inflammation and resolution. Mol Interv. 6:199–207. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kapoor M, Shaw O and Appleton I: Possible
anti-inflammatory role of COX-2-derived prostaglandins:
Implications for inflammation research. Curr Opin Investig Drugs.
6:461–466. 2005.PubMed/NCBI
|
|
28
|
Idanpaan-Heikkila JE, Idanpaan-Heikkila JJ
and Klaukka T: Treatment for inflammation related pain - COX-2
inhibitors knocking on the door. Duodecim. 120:229–234. 2004.In
Finnish.
|
|
29
|
del Zoppo G, Ginis I, Hallenbeck JM,
Iadecola C, Wang X and Feuerstein GZ: Inflammation and stroke:
Putative role for cytokines, adhesion molecules and iNOS in brain
response to ischemia. Brain Pathol. 10:95–112. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Predonzani A, Cali B, Agnellini AH and
Molon B: Spotlights on immunological effects of reactive nitrogen
species: When inflammation says nitric oxide. World J Exp Med.
5:64–76. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mittal M, Siddiqui MR, Tran K, Reddy SP
and Malik AB: Reactive oxygen species in inflammation and tissue
injury. Antioxid Redox Signal. 20:1126–1167. 2014. View Article : Google Scholar :
|
|
32
|
Harijith A, Ebenezer DL and Natarajan V:
Reactive oxygen species at the crossroads of inflammasome and
inflammation. Front Physiol. 5:3522014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fan Y, Mao R and Yang J: NF-kappaB and
STAT3 signaling pathways collaboratively link inflammation to
cancer. Protein Cell. 4:176–185. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lawrence T: The nuclear factor NF-kappaB
pathway in inflammation. Cold Spring Harb Perspect Biol.
1:a0016512009. View Article : Google Scholar
|
|
35
|
Ali S and Mann DA: Signal transduction via
the NF-kappaB pathway: A targeted treatment modality for infection,
inflammation and repair. Cell Biochem Funct. 22:67–79. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gilmore TD: The Rel/NF-kappaB signal
transduction pathway: Introduction. Oncogene. 18:6842–6844. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Schieven GL: The biology of p38 kinase: A
central role in inflammation. Curr Top Med Chem. 5:921–928. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ip YT and Davis RJ: Signal transduction by
the c-Jun N-terminal kinase (JNK) - from inflammation to
development. Curr Opin Cell Biol. 10:205–219. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Haddad JJ: The role of inflammatory
cytokines and NF-kappaB/MAPK signaling pathways in the evolution of
familial Mediterranean fever: Current clinical perspectives and
potential therapeutic approaches. Cell Immunol. 260:6–13. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Saklatvala J: Inflammatory signaling in
cartilage: MAPK and NF-kappaB pathways in chondrocytes and the use
of inhibitors for research into pathogenesis and therapy of
osteoarthritis. Curr Drug Targets. 8:305–313. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Schulert GS and Grom AA: Pathogenesis of
macrophage activation syndrome and potential for cytokine- directed
therapies. Annu Rev Med. 66:145–159. 2015. View Article : Google Scholar
|
|
42
|
Sierra-Filardi E, Nieto C, Dominguez-Soto
A, Barroso R, Sanchez-Mateos P, Puig-Kroger A, Lopez-Bravo M, Joven
J, Ardavin C, Rodriguez-Fernandez JL, et al: CCL2 shapes macrophage
polarization by GM-CSF and M-CSF: Identification of
CCL2/CCR2-dependent gene expression profile. J Immunol.
192:3858–3867. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chen S, Jiao J, Jiang D, Wan Z, Li L, Li
K, Xu L, Zhou Z, Xu W and Xiao J: T-box transcription factor
Brachyury in lung cancer cells inhibits macrophage infiltration by
suppressing CCL2 and CCL4 chemokines. Tumour Biol. 36:5881–5890.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Datar I, Qiu X, Ma HZ, Yeung M, Aras S, de
la Serna I, Al-Mulla F, Thiery JP, Trumbly R, Fan X, et al: RKIP
regulates CCL5 expression to inhibit breast cancer invasion and
metastasis by controlling macrophage infiltration. Oncotarget.
6:39050–39061. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Tsang MS, Jiao D, Chan BC, Hon K-L, Leung
P, Lau C, Wong E, Cheng L, Chan C, Lam C, et al: Anti-inflammatory
activities of pentaherbs formula, berberine, gallic acid and
chlorogenic acid in atopic dermatitis-like skin inflammation.
Molecules. 21:5192016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Washio K, Kobayashi M, Saito N, Amagasa M
and Kitamura H: Propolis ethanol extract stimulates cytokine and
chemokine production through NF-κB activation in C2C12 myoblasts.
Evid Based Complement Alternat Med. 2015:3497512015. View Article : Google Scholar
|
|
47
|
Meng ZQ, Tang ZH, Yan YX, Guo CR, Cao L,
Ding G, Huang WZ, Wang ZZ, Wang KD, Xiao W, et al: Study on the
anti-gout activity of chlorogenic acid: Improvement on
hyperuricemia and gouty inflammation. Am J Chin Med. 42:1471–1483.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Zheng Z, Sheng Y, Lu B and Ji L: The
therapeutic detoxification of chlorogenic acid against
acetaminophen-induced liver injury by ameliorating hepatic
inflammation. Chem Biol Interact. 238:93–101. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Shi H, Dong L, Jiang J, Zhao J, Zhao G,
Dang X, Lu X and Jia M: Chlorogenic acid reduces liver inflammation
and fibrosis through inhibition of toll-like receptor 4 signaling
pathway. Toxicology. 303:107–114. 2013. View Article : Google Scholar
|
|
50
|
Feng Y, Yu YH, Wang ST, Ren J, Camer D,
Hua YZ, Zhang Q, Huang J, Xue DL, Zhang XF, et al: Chlorogenic acid
protects D-galactose-induced liver and kidney injury via
antioxidation and anti-inflammation effects in mice. Pharm Biol.
54:1027–1034. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Lin K, Liu S, Shen Y and Li Q: Berberine
attenuates cigarette smoke-induced acute lung inflammation.
Inflammation. 36:1079–1086. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Li Z, Zheng J, Zhang N and Li C: Berberine
improves airway inflammation and inhibits NF-kappaB signaling
pathway in an ovalbumin-induced rat model of asthma. J Asthma.
53:999–1005. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Yu L, Li Q, Yu B, Yang Y, Jin Z, Duan W,
Zhao G, Zhai M, Liu L, Yi D, et al: Berberine attenuates myocardial
ischemia/reper-fusion injury by reducing oxidative stress and
inflammation response: Role of silent information regulator 1. Oxid
Med Cell Longev. 2016:16896022016. View Article : Google Scholar
|
|
54
|
Kim BY, Park HR, Jeong HG and Kim SW:
Berberine reduce allergic inflammation in a house dust mite
allergic rhinitis mouse model. Rhinology. 53:353–358.
2015.PubMed/NCBI
|
|
55
|
Jiang Q, Liu P, Wu X, Liu W, Shen X, Lan
T, Xu S, Peng J, Xie X and Huang H: Berberine attenuates
lipopolysaccharide-induced extracelluar matrix accumulation and
inflammation in rat mesangial cells: Involvement of NF-kappaB
signaling pathway. Mol Cell Endocrinol. 331:34–40. 2011. View Article : Google Scholar
|
|
56
|
Li H, Zhu L, Yuan G, Heng S, Yi B, Ma C,
Shen J, Tu J, Fu T and Wen J: Fine mapping and candidate gene
analysis of an anthocyanin-rich gene, BnaA.PL1 conferring purple
leaves in Brassica napus L. Molecular genetics and genomics. MGG.
291:1523–1534. 2016. View Article : Google Scholar
|
